CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Jan 12, 2015 11:04am EST

Another Clinical Trial for CollPlant: Trials for Vergenix®STR Have Begun - a Human Collagen-based Product for Tendon Repair

Dec 01, 2014 7:00am EST

CollPlant Launched a Clinical Trial With Vergenix®FG; A Gel Based on a Human Collagen for the Treatment of Chronic Wounds

Sep 08, 2014 6:26am EDT

CollPlant Names Dr. Nadav Orr Vice President Research and Development

Jun 23, 2014 9:16am EDT

CollPlant Holds Intellectual Property Rights in USA - One of the Largest Target Markets for the Company's Products: US Patent Office Approves Patent for Company's Collagen Production Techniques

Jun 16, 2014 11:53am EDT

CollPlant Takes a Step Closer to Commercializing its Vergenix Flowable Gel Product for Treating Wounds: Receives Approval to Carry Out Clinical Trial

Dec 17, 2012 8:28am EST

CollPlant Takes Significant Steps Towards Sales in Europe

RSS
  • Prev
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2023 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20